Form 8-K - Current report:
SEC Accession No. 0000950142-24-002817
Filing Date
2024-11-21
Accepted
2024-11-21 08:05:41
Documents
13
Period of Report
2024-11-15
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh240560212_8k.htm   iXBRL 8-K 24414
  Complete submission text file 0000950142-24-002817.txt   197744

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tcrx-20241115.xsd EX-101.SCH 3030
3 XBRL LABEL FILE tcrx-20241115_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE tcrx-20241115_pre.xml EX-101.PRE 22369
15 EXTRACTED XBRL INSTANCE DOCUMENT eh240560212_8k_htm.xml XML 3676
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 241482217
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)